Drug General Information
Drug ID	D07EFI
Former ID	DNC013733
Drug Name	1-(4-Methylpent-3-en-2-ylidene)thiosemicarbazide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529513]
Structure		Download 2D MOL 3D MOL
Formula	C7H13N3S
Canonical SMILES	CC(=CC(=NNC(=S)N)C)C
InChI	1S/C7H13N3S/c1-5(2)4-6(3)9-10-7(8)11/h4H,1-3H3,(H3,8,10,11)/b9-6-
InChIKey	KSBSSDJKRMIXES-TWGQIWQCSA-N
PubChem Compound ID	44583134
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[529513]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 529513	Eur J Med Chem. 2009 Apr;44(4):1773-8. Epub 2008 Apr 27.A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.
Ref 529513	Eur J Med Chem. 2009 Apr;44(4):1773-8. Epub 2008 Apr 27.A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.